• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Tuesday, March 28, 2023
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home National

WHO Warns Against Use Of Ivermectin For COVID-19 Treatment

by The Outlooker Web Desk
May 11, 2021
in National
0
WHO Warns Against Use Of Ivermectin For COVID-19 Treatment
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

‘Ivermectin’ is an orally given drug used – in specific doses – to treat parasitic infections (File)

New Delhi:

The World Health Organization on Tuesday recommended against the general use of ‘ivermectin’ – an orally-administered drug used to treat parasitic infections – for treatment of COVID-19 patients.

“Safety and efficacy are important when using any drug for a new indication. WHO recommends against use of ‘ivermectin’ for COVID-19 except within clinical trials,” Dr Soumya Swaminathan, the global health body’s chief scientist, tweeted.

A similar warning has also been issued by German healthcare and life sciences giant Merck, whose statement Dr Swaminathan attached to her tweet. Merck said its scientists continue to “carefully examine findings of all available and emerging studies of ‘ivermectin’ for treatment of COVID-19”.

“We do not believe the data available support the safety and efficacy of ‘ivermectin’ beyond the doses and populations indicated in the regulatory agency-approved prescribing information,” Merck said.

Safety and efficacy are important when using any drug for a new indication. @WHO recommends against the use of ivermectin for #COVID19 except within clinical trials https://t.co/dSbDiW5tCW

— Soumya Swaminathan (@doctorsoumya) May 10, 2021

This is the second WHO warning against ‘ivermectin’ in the past two months. In March it said there is “very low certainty of evidence” of the drug’s effect on mortality or hospital admission.

“We currently lack persuasive evidence of a mechanism of action for ‘ivermectin’ in COVID-19, and any observed clinical benefit would be unexplained,” the WHO said at that time.

Dr Swaminathan’s tweet today comes a day after Goa approved use of ‘ivermectin’ as preventive treatment for all adults against the SARS-CoV2 virus that causes the COVID-19 disease.

Goa Health Minister Vishwajit P Rane said the state’s green-lighting of the drug was after expert panels from the United Kingdom, Italy, Spain and Japan found a “statistically significant reduction in mortality, time to recovery, and viral clearance in COVID-19 patients treated with ‘ivermectin'”.

Mr Rane said treatment – 12 mg for five days – would be available for everyone over 18.

Patients will be treated with Ivermectin 12mg for a period of 5 days. Expert panels from the UK, Italy, Spain and Japan, found a large, statistically significant reduction in mortality, time to recovery and viral clearance in Covid-19 patients treated with Ivermectin. (2/4)

— VishwajitRane (@visrane) May 10, 2021

“This does not prevent Covid-19 infection but helps in reducing the severity of the disease…” he added.

However, this does not prevent Covid-19 infection but helps in reducing the severity of the disease and at the same time one should not have a false sense of security and complacency but strictly take all the precautionary measures and follow laid SOP’s. (3/4)

— VishwajitRane (@visrane) May 10, 2021

The WHO chief scientist’s tweet is important given growing debate over the efficacy of ‘ivermectin’, which is approved – in specific doses – for infections caused by some parasitic worms.

It is not, at this stage, viewed as an antiviral drug; which is something the United States’ Food and Drug Administration has stressed, saying, “Ivermectin is not approved for COVID-19 treatment.”

There are, however, some studies that suggest the opposite.

A review of available data – published in the May-June issue of the American Journal of Therapeutics – claims ‘ivermectin’ can help end the pandemic.

“We conducted the most comprehensive review of the available data on ivermectin,” Pierre Kory, President and Chief Medical Officer of the Front Line COVID-19 Critical Care Alliance (FLCCC) – a group of medical and scientific experts that led the study – said.

The authors have claimed a large and statistically significant reduction in mortality, time to recovery, and viral clearance in COVID-19 patients treated with ‘ivermectin’.

‘Ivermectin’ is one of a number of drugs, antiviral or otherwise, being studied for and offered as COVID-19 treatment options. Others include Remdesivir – which is in great demand in India – and anti-malaria drug hydroxychloroquine – large quantities of which were exported by India last year.

The WHO has still not approved hydroxychloroquine and, last month, the centre said remdesivir is not a life-saving drug and its “unnecessary or irrational” use on Covid patients is unethical.

Remdesivir is, however, routinely recommended for treatment in India.

Medication to treat or lessen the impact of COVID-19 continue to make headlines in India and around the world, as many countries battle devastating waves of the infection.

This morning India, the current epicentre of the pandemic, reported over 3.2 lakh new cases and 3,876 deaths in the past 24 hours. The number of active cases is now over 37.15 lakh.

With input from AFP, PTI

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
Blackstone-backed Sona BLW Precision Forgings gets SEBI nod for IPO; plans to raise Rs 6,000 crore

Blackstone-backed Sona BLW Precision Forgings gets SEBI nod for IPO; plans to raise Rs 6,000 crore

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Gandhi Family Is Congress Pivot, Keeps Party United: Ashok Gehlot
National

Gandhi Family Is Congress Pivot, Keeps Party United: Ashok Gehlot

March 28, 2023
18 Pharma Companies To Lose Licenses Over Poor Quality Medicines: Sources
National

18 Pharma Companies To Lose Licenses Over Poor Quality Medicines: Sources

March 28, 2023
UP Gangster Atiq Ahmed Found Guilty In Kidnapping Case
National

UP Gangster Atiq Ahmed Found Guilty In Kidnapping Case

March 28, 2023
Bureaucrat Swims From Gateway Of India To Elephanta Caves In Less Than 6 Hours
National

Bureaucrat Swims From Gateway Of India To Elephanta Caves In Less Than 6 Hours

March 28, 2023

Connect with us

No Result
View All Result

Archives

  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Gandhi Family Is Congress Pivot, Keeps Party United: Ashok Gehlot
  • 18 Pharma Companies To Lose Licenses Over Poor Quality Medicines: Sources
  • UP Gangster Atiq Ahmed Found Guilty In Kidnapping Case

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.